Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nL-ASXL3-001 in Bainbridge-Ropers Syndrome
NCT07197268Phase 2Active, not recruiting
- Sponsor
- n-Lorem Foundation
- Start
- May 2025
- Primary completion
- May 2027
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of nL-ASXL3-001 in Bainbridge-Ropers syndrome (BRPS), sponsored by n-Lorem Foundation. Started May 2025; status: active, not recruiting.
02
Drugs
nL-ASXL3-001
03
Conditions
Bainbridge-Ropers syndrome (BRPS)
Beyond the preview
Go deeper on NCT07197268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07197268.